InsiderBoltOpen live tracker
Home › Stocks › ARTV insider trading

ARTV insider trading — Artiva Biotherapeutics, Inc.

Over the last 90 days, insiders at Artiva Biotherapeutics, Inc. (ARTV) made 8 open-market purchases worth $4.88M and 8 open-market sales worth $1.47M, making them net buyers by $3.41M. The largest purchase was by Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M. (Director), who bought 152,472 shares for $1.36M on Jul 16, 2026. The largest sale was by Aslan Fred (Chief Executive Officer), who sold 61,888 shares for $690K on Sep 3, 2026.

Updated Oct 16, 2026.

Insider buying · 90d
$4.88M
Insider selling · 90d
$1.47M
Net · 90d
+$3.41M
Last 30 days
0B / 4S

Scan ARTV live in the tracker

Recent ARTV insider transactions

Every Form 4 filed by Artiva Biotherapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.

Trade dateInsiderRoleTypeOwnershipSharesPriceValueFiling
Oct 6, 2026Aslan FredChief Executive OfficerS · Sale · 10b5-1Direct23,463$7.20$169KForm 4
Oct 5, 2026Bush JenniferCOO, CLO, Compliance OfficerS · SaleDirect8,370$6.84$57KForm 4
Oct 5, 2026Horan ChristopherChief Tech Operations OfficerS · SaleDirect10,340$6.84$71KForm 4
Oct 5, 2026Banerjee SubhashisChief Medical OfficerS · SaleDirect1,099$6.84$8KForm 4
Oct 5, 2026Aslan FredChief Executive OfficerS · SaleDirect61,696$6.84$422KForm 4
Sep 15, 2026Aslan FredChief Executive OfficerA · Grant/awardDirect110,000——Form 4
Sep 10, 2026Aslan FredChief Executive OfficerA · Grant/awardDirect45,000——Form 4
Sep 9, 2026Miralles Gines DiegoPresident & Head of R&DA · Grant/awardDirect45,000——Form 4
Sep 9, 2026Bush JenniferCOO, CLO, Compliance OfficerA · Grant/awardDirect45,000——Form 4
Sep 9, 2026Horan ChristopherChief Tech Operations OfficerA · Grant/awardDirect40,000——Form 4
Sep 9, 2026Banerjee SubhashisChief Medical OfficerA · Grant/awardDirect30,000——Form 4
Sep 8, 2026Aslan FredChief Executive OfficerS · Sale · 10b5-1Direct23,429$10.92$256KForm 4
Sep 3, 2026Horan ChristopherChief Tech Operations OfficerS · SaleDirect10,366$11.16$116KForm 4
Sep 3, 2026Bush JenniferCOO, CLO, Compliance OfficerS · SaleDirect8,391$11.16$94KForm 4
Sep 3, 2026Banerjee SubhashisChief Medical OfficerS · SaleDirect1,100$11.16$12KForm 4
Sep 3, 2026Aslan FredChief Executive OfficerS · SaleDirect61,888$11.16$690KForm 4
Aug 27, 2026Banerjee SubhashisChief Medical OfficerM · Option exercise · 10b5-1Direct5,306$1.92$10KForm 4
Aug 27, 2026Banerjee SubhashisChief Medical OfficerS · Sale · 10b5-1Direct8,222$12.01$99KForm 4
Aug 18, 2026Banerjee SubhashisChief Medical OfficerM · Option exercise · 10b5-1Direct429$1.92$824Form 4
Aug 18, 2026Banerjee SubhashisChief Medical OfficerS · Sale · 10b5-1Direct429$12.00$5KForm 4
Jul 31, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect24,944$9.93$248KForm 4
Jul 29, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect20,824$9.99$208KForm 4
Jul 24, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect41,319$9.99$413KForm 4
Jul 23, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect59,880$9.96$596KForm 4
Jul 22, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect84,124$9.93$835KForm 4
Jul 21, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect120,582$9.55$1.15MForm 4
Jul 17, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect7,882$8.95$71KForm 4
Jul 16, 2026Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.DirectorP · PurchaseIndirect152,472$8.93$1.36MForm 4

ARTV insider trading FAQ

Are insiders buying ARTV stock?

Yes. In the last 90 days, Artiva Biotherapeutics, Inc. insiders made 8 open-market purchases totaling $4.88M, and 8 open-market sales totaling $1.47M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).

Who are the insiders trading ARTV?

Recent buyers: Ra Capital Management, L.P., Ra Capital Healthcare Fund Lp, Ra Capital Nexus Fund, L.P., Ra Capital Nexus Fund Iii, L.P., Kolchinsky Peter, Shah Rajeev M.. Recent sellers: Aslan Fred, Banerjee Subhashis, Bush Jennifer, Horan Christopher.

Where does ARTV insider trading data come from?

Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.

More stocks with insider activity

NYAXNayax Ltd.KBDCKayne Anderson BDC, Inc.GMEGameStop Corp.GSATGlobalstar, Inc.BCBPBCB Bancorp IncFULFuller H B CoBWMXBetterware de Mexico, S.A.P.I. de C.VFGBIFirst Guaranty Bancshares, Inc.BORRBorr Drilling LtdAGMBAgomAb Therapeutics NVHHHHoward Hughes Holdings Inc.CVCapsoVision, Inc

Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.